TIME IS BRAIN
DEAD

Serial Number

78793870

Owner

Paion Deutschland GmbH

Attorney

GARY D. KRUGMAN

Filing Date

Jan 18, 2006

Add to watchlist:

No watchlists yet
View on USPTO

TIME IS BRAIN Trademark

Serial Number: 78793870 • Registration: 3297427

TIME IS BRAIN is a trademark filed by Paion Deutschland GmbH on January 18, 2006. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Paion Deutschland GmbH (11 trademarks)

Martinstr. 10-12
52062 Aachen , DE

Entity Type: 99

Trademark Details

Filing Date

January 18, 2006

Registration Date

September 25, 2007

Published for Opposition

July 10, 2007

Cancellation Date

May 2, 2014

Goods & Services

Educational services, namely, providing seminars, informational events and/or workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, gendiagnostics

Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment and diagnosis of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutriceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical preparations, namely, thrombolytic, fibrinolytic anti-coagulative, antithrombotical or neuroprotective substances for the treatment of blood clotting, cell protection and cell regeneration; products from biotechnological methods, namely, proteins fortherapeutic and diagnostic use in the treatment and diagnosis of blood clotting disorders; blood clotting test kits comprised of medical diagnostic reagents; medical and clinical diagnostic reagents for clinical or medical laboratory use

Computerized database management, namely, editing, evaluating and processing data for third parties; performance of pre-clinical studies, namely, managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products

Reagents for scientific or medical research use; diagnostic preparations or reagents for scientific or research use, biochemical reagents for scientific or medical research use; biochemical diagnostic preparations or reagents for scientific or research use

Laboratory devices for medical and pharmaceutical investigations, namely, portable medical devices for conducting medical diagnostic tests and blood specimen analysis of the human blood clotting system; medical devices, namely, coated catheters, medical stents, surgical implants comprising artificial materials; membranes intended for medical use, namely, filters for dialysis, hemofiltration

Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; licensing of intellectual property; services of a biotechnological laboratory, namely, conducting lab research for others in the field of drug research and development; pharmaceutical consulting, namely, providing pharmaceutical advice to others regarding governmental regulatory laws and practices, performing pre-clinical studies, quality control; preparation of expert opinions in the field of chemical engineering, biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry, product research and development of medical devices and pharmaceutical preparations, and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the area of protein identification, design and development, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins; diagnostic services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries; performance of pre-clinical studies, namely, conducting pre-clinical trials and studies of pharmaceutical, bio-technology and health care products; bio-chemical and biotechnological research and development for others, namely, bio-technological research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment; scientific research on and development of medical diagnostic equipment and pharmaceutical preparations and products for the treatment of stroke, neuron damage, thrombotic diseases, tumors, cancer, heart diseases including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others, namely, prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA-microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment

Filing History

CANCELLED SEC. 8 (6-YR)
May 2, 2014 C8..
REGISTERED-PRINCIPAL REGISTER
Sep 25, 2007 R.PR
PUBLISHED FOR OPPOSITION
Jul 10, 2007 PUBO
NOTICE OF PUBLICATION
Jun 20, 2007 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 1, 2007 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2007 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 27, 2007 XAEC
EXAMINERS AMENDMENT E-MAILED
Apr 27, 2007 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 27, 2007 CNEA
LETTER OF SUSPENSION E-MAILED
Feb 2, 2007 GNSL
SUSPENSION LETTER WRITTEN
Feb 2, 2007 CNSL
AMENDMENT FROM APPLICANT ENTERED
Jan 31, 2007 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2007 CRFA
ASSIGNED TO LIE
Jan 31, 2007 ALIE
PAPER RECEIVED
Jan 5, 2007 MAIL
NON-FINAL ACTION E-MAILED
Jul 10, 2006 GNRT
NON-FINAL ACTION WRITTEN
Jul 10, 2006 CNRT
ASSIGNED TO EXAMINER
Jul 7, 2006 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 22, 2006 AMPX
PAPER RECEIVED
Mar 22, 2006 MAIL
NEW APPLICATION ENTERED
Jan 24, 2006 NWAP